chinapharmaholdings.com (CPHI): Rasio utang marang kapitalisasi buku

China Pharma Holdings (CPHI) adheres to environmental standards by neutralizing chemical production waste. Financial leverage levels based on balance sheet capital help track the dynamics of liabilities, where 0.12 reflects the baseline level of the metric. The company produces mass-market psychotropic generics while facing rising raw material costs. Strict government price regulations and the risk of losing insurance reimbursements intensify competition within the Chinese sector.

Government price regulations on generics and environmental costs are exerting significant pressure on the margins of China Pharma Holdings (CPHI). This indicator compares total debt obligations against the company's net asset value. It determines the degree of financial leverage and the business's dependence on borrowed capital. It is critical for investors to monitor the risk of excessive debt load amid falling profits. Analyzing the ratio of borrowed funds to book capitalization allows for an assessment of the stability of the financing structure.